{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:47:16Z","timestamp":1781113636687,"version":"3.54.1"},"reference-count":130,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.micinf.2022.105078","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T14:17:04Z","timestamp":1669213024000},"page":"105078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?"],"prefix":"10.1016","volume":"25","author":[{"given":"Sharvan","family":"Sehrawat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5313-2176","authenticated-orcid":false,"given":"Nikolaus","family":"Osterrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Scott","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8829-0334","authenticated-orcid":false,"given":"Barry T.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2022.105078_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib2","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase","volume":"385","author":"El Sahly","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41577-020-00497-5","article-title":"A\u00a0guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2022.105078_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105078_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0264-410X(99)00271-6","article-title":"DNA and RNA-based vaccines: principles, progress and prospects","volume":"18","author":"Leitner","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2022.105078_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2022.105078_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105078_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","article-title":"Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine","volume":"23","author":"Li","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.micinf.2020.07.002","article-title":"Does the hygiene hypothesis apply to COVID-19 susceptibility?","volume":"22","author":"Sehrawat","year":"2020","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2022.105078_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jtm\/taac037","article-title":"The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta","volume":"29","author":"Liu","year":"2022","journal-title":"J\u00a0Trav Med"},{"key":"10.1016\/j.micinf.2022.105078_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105078_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cell.2020.04.031","article-title":"Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies","volume":"181","author":"Wrapp","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2022.105078_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2022.105078_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micinf.2022.105078_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41422-021-00603-9","article-title":"Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1","volume":"32","author":"Hoffmann","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.micinf.2022.105078_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.micinf.2022.105078_bib20","first-page":"370","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib21","first-page":"310","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","author":"Sette","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.micinf.2022.105078_bib22","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105078_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patients after acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.micinf.2022.105078_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","article-title":"Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases","volume":"163","author":"Zollner","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2022.105078_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medj.2022.04.001","article-title":"Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection","volume":"3","author":"Natarajan","year":"2022","journal-title":"Med"},{"key":"10.1016\/j.micinf.2022.105078_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","article-title":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis","volume":"159","author":"Cheung","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2022.105078_bib31","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.1701410114","article-title":"Emerging infectious diseases: a proactive approach","volume":"114","author":"Bloom","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2022.105078_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.micinf.2020.02.002","article-title":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future","volume":"22","author":"Li","year":"2020","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2022.105078_bib33","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.3389\/fimmu.2020.02130","article-title":"Viral emerging diseases: challenges in developing vaccination strategies","volume":"11","author":"Trovato","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00372","article-title":"Hemorrhagic fever-causing arenaviruses: lethal pathogens and potent immune suppressors","volume":"10","author":"Brisse","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2012.06.001","article-title":"Chandipura Virus: an emerging tropical pathogen","volume":"124","author":"Menghani","year":"2012","journal-title":"Acta Trop"},{"key":"10.1016\/j.micinf.2022.105078_bib36","first-page":"32","article-title":"Tradeoff analysis of the pork supply and food security under the influence of African swine fever and the COVID-19 outbreak in China","volume":"3","author":"Yao","year":"2022","journal-title":"Geogr Sustain"},{"key":"10.1016\/j.micinf.2022.105078_bib37","first-page":"248","article-title":"The evolution of African swine fever in China: a global threat?","author":"Ito","year":"2022","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.micinf.2022.105078_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib39","first-page":"564","volume":"344","author":"Urphy","year":"2001"},{"key":"10.1016\/j.micinf.2022.105078_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/gut.50.1.11","article-title":"The link between rotavirus vaccination and intussusception: implications for vaccine strategies","volume":"50","author":"Cale","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.micinf.2022.105078_bib41","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2205011","article-title":"BNT162b2 vaccine effectiveness against Omicron in children 5 to 11 Years of age","author":"Cohen-Stavi","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jama.2021.21625","article-title":"Why parents still hesitate to vaccinate their children against COVID-19","volume":"327","author":"Suran","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2022.105078_bib43","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","article-title":"A\u00a0multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice","volume":"28","author":"Freyn","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.micinf.2022.105078_bib44","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in\u00a0vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.micinf.2022.105078_bib45","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib47","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.aaq0215","article-title":"Advancing dengue vaccine development","volume":"358","author":"Feinberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib48","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","author":"Sridhar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib50","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-021-01392-9","article-title":"Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection","volume":"27","author":"Salje","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2022.105078_bib51","article-title":"Dengvaxia: the world's first vaccine for prevention of secondary dengue","volume":"9","author":"Tully","year":"2021","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.micinf.2022.105078_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102991","article-title":"Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models","volume":"60","author":"Shukla","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.micinf.2022.105078_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fimmu.2018.00597","article-title":"Modulation of Dengue\/Zika Virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika Virus infection","volume":"9","author":"Khandia","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib55","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2022.105078_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely high mutation rate of HIV-1 in\u00a0vivo","volume":"13","author":"Cuevas","year":"2015","journal-title":"PLoS Biol"},{"key":"10.1016\/j.micinf.2022.105078_bib57","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.micinf.2022.105078_bib58","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.20268","article-title":"A\u00a0critical role for the chimpanzee model in the study of hepatitis C","volume":"39","author":"Bukh","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.micinf.2022.105078_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2022.105078_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/vaccines7030107","article-title":"Original antigenic sin and respiratory syncytial virus vaccines","volume":"7","author":"Tripp","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.micinf.2022.105078_bib61","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.micinf.2022.105078_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.coviro.2017.03.012","article-title":"Vaccine development for respiratory syncytial virus","volume":"23","author":"Graham","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog"},{"issue":"Suppl 1","key":"10.1016\/j.micinf.2022.105078_bib64","article-title":"Immunopathogenesis of vaccine-enhanced RSV disease","volume":"20","author":"Openshaw","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2022.105078_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.micinf.2022.105078_bib66","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib67","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"McLellan","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/v14050862","article-title":"Fraternal twins: the enigmatic role of the immune system in alphaherpesvirus pathogenesis and latency and its impacts on vaccine efficacy","volume":"14","author":"Rouse","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2022.105078_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 Years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib70","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2022.105078_bib71","first-page":"406","article-title":"Shingrix: a new herpes zoster vaccine","volume":"44","author":"Maltz","year":"2019","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.micinf.2022.105078_bib72","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib73","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2005-11-012864","article-title":"Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants","volume":"108","author":"Lilleri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.micinf.2022.105078_bib74","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/512245","article-title":"Development of human cytomegalovirus\u2014specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus","volume":"195","author":"Lilleri","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib75","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/infdis\/164.5.835","article-title":"Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans","volume":"164","author":"Rasmussen","year":"1991","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib76","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2002-08-2502","article-title":"Primary immune responses to human CMV: a critical role for IFN-\u03b3-producing CD4+ T cells in protection against CMV disease","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.micinf.2022.105078_bib77","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/319680","article-title":"A\u00a0canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects","volume":"183","author":"Berencsi","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib78","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/314951","article-title":"A\u00a0canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated cmv vaccine (Towne)","volume":"180","author":"Adler","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib79","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/512245","article-title":"Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus","volume":"195","author":"Lilleri","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib80","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1469-0691.12449","article-title":"Cytomegalovirus vaccine: phase II clinical trial results","volume":"20","author":"Rieder","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.micinf.2022.105078_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005355","article-title":"The March towards a vaccine for congenital CMV: rationale and models","volume":"12","author":"Bialas","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2022.105078_bib82","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1093\/infdis\/jiz447","article-title":"The status of vaccine development against the human cytomegalovirus","volume":"221","author":"Plotkin","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib83","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles IN cultured lymphoblasts from BURKITT\u2019S lymphoma","volume":"283","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105078_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.623944","article-title":"Epstein barr virus and autoimmune responses in systemic lupus erythematosus","volume":"11","author":"Jog","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib85","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib86","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.3389\/fimmu.2020.587380","article-title":"Epstein-Barr virus and systemic autoimmune diseases","volume":"11","author":"Houen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib87","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1172\/JCI25078","article-title":"Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis","volume":"115","author":"Clute","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micinf.2022.105078_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01841-17","article-title":"Severity of acute infectious mononucleosis correlates with cross-reactive influenza CD8 T-cell receptor repertoires","volume":"8","author":"Aslan","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.micinf.2022.105078_bib89","doi-asserted-by":"crossref","first-page":"16286","DOI":"10.1073\/pnas.0407320101","article-title":"Proteins of purified Epstein-Barr virus","volume":"101","author":"Johannsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2022.105078_bib90","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fmicb.2017.00934","article-title":"Positively selected sites at HCMV gB furin processing region and their effects in cleavage efficiency","volume":"8","author":"Stangherlin","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2022.105078_bib91","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/vir.0.007237-0","article-title":"Cleavage of Epstein-barr virus glycoprotein B is required for full function in cell:cell fusion with both epithelial and B cells","volume":"90","author":"Sorem","year":"2009","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104549","article-title":"Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses","volume":"25","author":"Singh","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.micinf.2022.105078_bib93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0145-305X(99)00076-2","article-title":"Immunopathogenesis of chicken anemia virus infection","volume":"24","author":"Adair","year":"2000","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1637\/7271-090304R","article-title":"Chicken infectious anemia virus: an example of the ultimate host-parasite relationship","volume":"48","author":"Miller","year":"2004","journal-title":"Avian Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8010123","article-title":"mRNA vaccines encoding the HA protein of influenza A H1N1 virus delivered by cationic lipid nanoparticles induce protective immune responses in mice","volume":"8","author":"Zhuang","year":"2020","journal-title":"Vaccines"},{"issue":"5","key":"10.1016\/j.micinf.2022.105078_bib96","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3390\/v13050945","article-title":"Prevalence of neutralizing antibodies to canine distemper virus and response to vaccination in client-owned adult healthy dogs","volume":"13","author":"Bergman","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2022.105078_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.79.22.14122-14130.2005","article-title":"Acquisition of macrophage tropism during the pathogenesis of feline infectious peritonitis is determined by mutations in the feline coronavirus spike protein","volume":"79","author":"Rottier","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib98","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3389\/fimmu.2020.581076","article-title":"Perspective: reducing SARS-CoV2 infectivity and its associated immunopathology","volume":"11","author":"Dubey","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2965cfae-b77d-4014-8b7b-236e01a35492","article-title":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus","volume":"7","author":"Tseng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2022.105078_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1297-9716-43-16","article-title":"Recent progress in West Nile virus diagnosis and vaccination","volume":"43","author":"De Filette","year":"2012","journal-title":"Vet Res"},{"key":"10.1016\/j.micinf.2022.105078_bib101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.vetimm.2008.02.002","article-title":"A\u00a0West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse","volume":"123","author":"El Garch","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.micinf.2022.105078_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79855-1","article-title":"Safe and effective aerosolization of in\u00a0vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent","volume":"11","author":"Legere","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.micinf.2022.105078_bib103","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00027-18","article-title":"Development of a broadly accessible Venezuelan equine encephalitis virus replicon particle vaccine platform","volume":"92","author":"Agnihothram","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.77.22.12067-12073.2003","article-title":"Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis","volume":"77","author":"Antonis","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/0300985813501341","article-title":"Respiratory syncytial virus infection in cattle","volume":"51","author":"Sacco","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.micinf.2022.105078_bib106","first-page":"660","article-title":"Vaccine-associated fibrosarcoma in a cat","volume":"44","author":"Martin","year":"2003","journal-title":"Can Vet J"},{"key":"10.1016\/j.micinf.2022.105078_bib107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tvjl.2004.04.018","article-title":"Equine herpesviruses 1 (EHV-1) and 4 (EHV-4) - epidemiology, disease and immunoprophylaxis: a brief review","volume":"170","author":"Patel","year":"2005","journal-title":"Vet J"},{"key":"10.1016\/j.micinf.2022.105078_bib108","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fmicb.2019.02668","article-title":"EHV-1: a constant threat to the horse industry","volume":"10","author":"Oladunni","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2022.105078_bib109","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1073\/pnas.1222025110","article-title":"Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza","volume":"110","author":"Oldstone","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.micinf.2022.105078_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/JVI.01211-08","article-title":"Immunopathological basis of lymphocytic choriomeningitis virus-induced chorioretinitis and keratitis","volume":"83","author":"Zinkernagel","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib111","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1099\/0022-1317-76-2-381","article-title":"Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus","volume":"76","author":"Moskophidis","year":"1995","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/nri2802","article-title":"Immunity and immunopathology to viruses: what decides the outcome?","volume":"10","author":"Rouse","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib113","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/ceo.12785","article-title":"Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents","volume":"44","author":"Tsatsos","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.micinf.2022.105078_bib114","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.micinf.2017.12.014","article-title":"Application of our understanding of pathogenesis of herpetic stromal keratitis for novel therapy","volume":"20","author":"Rajasagi","year":"2018","journal-title":"Microb Infect"},{"key":"10.1016\/j.micinf.2022.105078_bib115","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.3389\/fimmu.2020.594963","article-title":"Virus infections and host metabolism\u2014can we manage the interactions?","volume":"11","author":"Sumbria","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fimmu.2017.00341","article-title":"Interplay of regulatory T cell and Th17 cells during infectious diseases in humans and animals","volume":"8","author":"Sehrawat","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib117","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3389\/fimmu.2021.735643","article-title":"Tissue-resident-memory CD8+ T cells bridge innate immune responses in neighboring epithelial cells to control human genital herpes","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/v13030359","article-title":"The role of tissue resident memory CD4 T cells in herpes simplex viral and HIV infection","volume":"13","author":"O\u2019neil","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2022.105078_bib119","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.1068284","article-title":"Outbreak of poliomyelitis in hispaniola associated with circulating type 1 vaccine-derived poliovirus","volume":"296","author":"Kew","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib120","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/S0140-6736(10)61230-5","article-title":"Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial","volume":"376","author":"Sutter","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2022.105078_bib121","doi-asserted-by":"crossref","first-page":"S398","DOI":"10.1093\/infdis\/jiaa622","article-title":"Immunization against poliomyelitis and the challenges to worldwide poliomyelitis eradication","volume":"224","author":"Modlin","year":"2021","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2022.105078_bib122","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.288.5471.1593","article-title":"A\u00a0brief history of polio vaccines","volume":"288","author":"Blume","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.micinf.2022.105078_bib123","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1099\/0022-1317-83-7-1707","article-title":"Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection","volume":"83","author":"Crotty","year":"2002","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib124","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/jvi.71.7.4915-4920.1997","article-title":"Expression of the poliovirus receptor in intestinal epithelial cells is not sufficient to permit poliovirus replication in the mouse gut","volume":"71","author":"Zhang","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2022.105078_bib125","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.3389\/fimmu.2021.772550","article-title":"Immunogenicity and protective potential of mucosal vaccine formulations based on conserved epitopes of influenza A viruses fused to an innovative ring nanoplatform in mice and chickens","volume":"12","author":"Calzas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00123","article-title":"Universal vaccines and vaccine platforms to protect against influenza viruses in humans and agriculture","volume":"9","author":"Raj\u00e3o","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2022.105078_bib127","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib128","doi-asserted-by":"crossref","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination","author":"Tang","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.micinf.2022.105078_bib129","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.micinf.2022.105078_bib130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.celrep.2012.03.009","article-title":"CD8+ T cells from mice transnuclear for a TCR that recognizes a single H-2Kb-restricted MHV68 epitope derived from gB-ORF8 help control infection","volume":"1","author":"Sehrawat","year":"2012","journal-title":"Cell Rep"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457922001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:41:20Z","timestamp":1761144080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457922001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":130,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1286457922001484"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105078","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals?","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2022.105078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105078"}}